Stock Track | Molina Healthcare Plunges 10% as Q4 Earnings Miss, Weak 2025 Guidance Overshadow Revenue Beat

Stock Track
06 Feb

Shares of Molina Healthcare Inc. (MOH) plummeted over 10% on Thursday's pre-market session after the health insurer reported mixed fourth-quarter results and issued underwhelming earnings guidance for 2025, overshadowing a revenue beat.

For the fourth quarter of 2024, Molina reported revenue of $10.499 billion, surpassing analysts' estimates of $10.32 billion. However, the company's adjusted earnings per share (EPS) of $5.05 fell short of the consensus estimate of $5.72.

Molina attributed the earnings miss to higher-than-expected medical costs, particularly in its Medicaid business. The company's medical care ratio (MCR), which measures medical costs as a percentage of premium revenue, stood at 90.2% in Q4, up from 89.1% a year earlier. The Medicaid MCR was 90.3%, reflecting the impact of redetermination-related acuity shifts and higher utilization.

Looking ahead, Molina forecasts 2025 revenue of approximately $44 billion, ahead of analysts' expectations of $43.4 billion. However, the company's adjusted EPS guidance of at least $24.50 fell short of the consensus estimate of around $26.07, owing to anticipated costs related to recent contract wins and acquisitions.

"I am very pleased our 2024 revenue growth exceeded our long-term targets and we produced consolidated pre-tax margins within our long-term target range," said Joseph Zubretsky, President and Chief Executive Officer. "Our earnings growth profile is solid heading into 2025, and we continue to execute on the long-term growth opportunities within all of our businesses."

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10